Watermark

BG-71332-101

Not yet recruiting

A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BG-71332-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 60 Years

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 60 Years

No Study Documents